Genmab — November 2018
-
Obs. Zealand Pharma Q&A starter kl. 15.
-
small new trial Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma (IDARA) https://clinicaltrials.gov/ct2/show/NCT03757221?term=NCT03757221&rank=1
-
Servicemeddelelse: Transcript fra Q&A med Zealand Pharma.
http://www.proinvestor.com/ir/q-and-a/dk -
Apropos mine betragtninger i går omkring markedsstemningen og Genmabs kurs: https://borsen.dk/nyheder/avisen/artikel/11/212984/artikel.html?hl=YToxOntpOjA7czo0OiJNYWRzIjt9&fbclid=IwAR2IhW1GP8TC-dxZPnA0193PHGL9SgsAl_GcGpmrAJm1fLKFycFCDSgf_iQ
-
glimrende hvis 2019 stort set byder på pause i rækken af renforhøjelser. Så er der nok nogen der skal have mere risiko på bogen https://ugebrev.dk/flashnews/investering/fed-renteforventninger-styrtdykker-nu-ventes-kun-en-renteforhoejelse/
-
Powell Economic Club speech, November 28
Federal Reserve Chair Jay Powell said at the Economic Club of New York on Wednesday that interest rates are "just below" the neutral rate that would sustain economic growth over the long term, a remark investors are cheering.
Yahoo Finance (finance.yahoo.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind